The 2nd Annual Meeting of the International Academy for Clinical Hematology (IACH)
Les Salons De L’Aveyron

Paris, France
http://iach2019.cme-congresses.com/faculty/
The 2nd Annual Meeting of the International Academy for Clinical Hematology (IACH)
CME Congresses
http://iach2019.cme-congresses.com/faculty/
Les Salons De L’Aveyron
Paris
France

Schedule of Presentations:

Thursday, September 19, 2019
06:00:00 New Presentation
09:00:00 Session F1B: Allogeneic stem cell transplant indications and results Jordi Sierra, Ibrahim Yakoub-Agha
09:00:00 Acute lymphoblastic leukemia Sebastian Giebel
09:00:00 Management of elderly myeloma Thierry Facon
09:20:00 Management of transplant-eligible myeloma Mohamad Mohty
09:40:00 Management of extra-medullary and high-risk myeloma
10:00:00 Relapsed myeloma Meral Beksaç
13:30:00 New PresentationHematology hot news session: advances in disease biology Arnon Nagler, Irene Ghobrial
13:30:00 Introduction to IACH activities and projects Arnon Nagler, Mohamad Mohty
14:00:00 Waldenstrom macroglobulinemia Irene Ghobrial
14:40:00 Myelodysplastic syndromes Ghulam Mufti
15:00:00 Multiple myeloma Robert Orlowski
15:20:00 ITP Jenny Despotovic
15:40:00 COFFEE BREAK
16:00:00 Current recommendation for TKI cessation in chronic myeloid leukemia (CML) F François Guilhot
16:00:00 Plenary Session 1: Advances in hematology He Huang, Mohamad Mohty
16:20:00 CAR T cells: experience from China He Huang
16:20:00 New insights in NPM1-1 mutated AML Brunangelo Falini
16:40:00 Next generation CAR T cells Saad Kenderian
17:00:00 Chronic lymphocytic leukemia: state-of-the-art therapy Gianluca Gaidano
17:30:00 Short Break
17:45:00 Opening Session: Keynote opening lecture and award presentation Arnon Nagler, Mohamad Mohty
17:45:00 Presentation of the H.J. Khoury excellence in research award
18:00:00 Management of elderly myeloma: 30 years of active research Thierry Facon
18:30:00 Welcome Reception
Friday, September 20, 2019
06:00:00 New Presentation Thomas Prebet
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
09:00:00 Session F1A: Multiple myeloma Meral Beksaç, Thierry Facon
09:20:00 Acute myeloid leukemia Arnon Nagler
09:40:00 Myelodysplastic syndromes Ibrahim Yakoub-Agha
10:00:00 Myeloproliferative neoplasms Naveen Pemmaraju
10:20:00 Discussion
10:20:00 Discussion
10:30:00 Short Break
10:45:00 Driving a change in outcomes for high-risk AML* and hepatic veno-occlusive disease *High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC) Industry-supported Lunch Symposium (Hall A)
12:15:00 Lunch Break
12:45:00 APL
12:45:00 Management of CMV infections Rafael Duarte
13:05:00 Late events after reduced-intensity conditioning Avichai Shimoni
13:05:00 Risk stratification in AML
13:25:00 Coronary and artery disease Minoo Battiwalla
13:25:00 Management of elderly AML Thomas Prebet
13:45:00 Management of young AML (outside transplant Jordi Sierra
13:45:00 Long-term complications after HCT Minoo Battiwalla
14:05:00 Discussion
14:05:00 Discussion
14:15:00 Break, Poster Viewing and Visit Exhibition
14:45:00 Mantle cell lymphoma Olivier Hermine
14:45:00 Session F3A: Non-Hodgkin lymphoma MA Kharfan-Dabaja
14:45:00 Endothelium-related complications
15:05:00 High-grade lymphoma Christian Gisselbrecht
15:05:00 How I prevent GVHD
15:25:00 Indolent lymphoma Olivier Hermine
15:25:00 Therapy of acute GVHD Ernst Holler
15:45:00 Chronic lymphocytic leukemia MA Kharfan-Dabaja
15:45:00 Challenges in chronic GVHD clinical trials Iskra Pusic
16:05:00 Discussion
16:05:00 Discussion
16:15:00 Coffee Break, Poster Viewing and Visit Exhibition
16:30:00 CAR T cells in ALL
16:30:00 Session F4B: Advances in allogeneic stem cell transplantation Avichai Shimoni, Didier Blaise
16:30:00 Session F4A: Acute lymphoblastic leukemia (ALL) Sebastian Giebel , Hagop Kantarjian
16:50:00 Conditioning for haplo-identical transplantation Didier Blaise
16:50:00 Novel antibodies in relapsed/refractory ALL
17:10:00 Which intensity of therapy is required in ALL? Dieter Hoelzer
17:30:00 Management of elderly ALL Hagop Kantarjian
17:50:00 Discussion
18:00:00 How to write a good paper
18:00:00 Current status in CLL Ilaria Del Giudice
18:00:00 Session F5B: Case report forum Michael Byrne, Mohamad Mohty
18:20:00 Current status in AML Christopher Hourigan
18:20:00 A complex transplant case (1) Jean El-Cheikh
18:30:00 A complex transplant case (2)
18:40:00 Barriers to clinical trial enrollment in HSCT Michael Byrne
18:40:00 Current status in ALL
18:50:00 Discussion
Saturday, September 21, 2019
06:00:00 New Presentation
08:00:00 Session S1A: Transfusion medicine and haemostasis
08:00:00 Session S1B: Red blood cell disorders Ali Taher
09:00:00 Session S2A: Platelet disorders Stephane Giraudier, James B. Bussel
09:00:00 Session S2A: Platelet disorders Stephane Giraudier, James B. Bussel
09:00:00 Session S2B: Iron-related disorders Ali Taher
10:30:00 Session S3A: Management of aplastic anemia, MDS and sAML Elena Solomou, Thomas Cluzeau
10:30:00 Session S3B: Toxicities in HSCT Britta Engelhardt, Navneet Majhail
11:45:00 CAR T cells in lymphoid malignancies: current status and perspectives Non-profit Lunch Symposium (Hall A)
13:15:00 Session S4A: Management of Hodgkin lymphoma and rare T cell NHLs Owen A. O’Connor, A Bazarbachi
14:45:00 Session S5B: Making the right diagnosis in hematology Elad Jacoby
14:45:00 Session S5A: Clinical experiences from around the world Shinichiro Okamoto
16:15:00 Coffee Break, Poster Viewing and Visit Exhibition
16:45:00 Plenary Session 2: State-of-the-art management of … Anas Younes, Jean-Luc Harousseau
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.